Workshop on HPV Immunization

October 8, 2017 - 8.30 – 12.00


Coordinator: Pierre Van Damme (Belgium)

This workshop addresses frequently asked question related to vaccine effectiveness, schedules and safety aspects. It allows to understand the rationale for vaccination of boys, offers an update on the HPV-9 vaccine, appreciates the impact of immunization on screening policies, and gives guidance on how to inform parents about vaccination to continue trust in HPV vaccines and HPV programs.

8.30 -8.35 Introduction to the workshop on HPV vaccines and vaccination P. Van Damme
8.35 – 9.00 Review on HPV vaccine safety P. Lopalco 20‘
+ 5‘ questions
9.00 – 9.25 One dose HPV vaccination programs: for tomorrow? M. Stanley 20’
+ 5’ discussion
9.25 – 9.50 Vaccination of boys: universally accepted? J. Brotherton 20’
+ 5’ discussion
9.50 – 10.00 Wrap-up of the first part  
10.00 – 10.30 Coffee break  
10.30 - 10.55 HPV-9 vaccine: all we need to know! E. Joura
10.55 – 11.20 Impact of vaccination on screening programs: what can we say today? E. Franco
11.20 – 11.45 Vaccine trust and HPV vaccines: where are we and what do we need to do? E. Karafillakis
11.45 – 12.00 Questions & answers and wrap-up  
  (additional topic to be confirmed)
How to communicate about HPV vaccines in the media
G. Finnighan
VaccinesToday, Brussels

About EUROGIN

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) brings together clinicians and scientists whose work is related to genital infections and neoplasia.

Newsletter